Skip to Content

125SLXP (Mytesi crofelemer delayed-release 125 mg)

Generic Name: crofelemer

Pill imprint 125SLXP has been identified as Mytesi crofelemer delayed-release 125 mg.

Mytesi is used in the treatment of diarrhea and belongs to the drug class antidiarrheals. Risk cannot be ruled out during pregnancy. Mytesi crofelemer delayed-release 125 mg is not a controlled substance under the Controlled Substance Act (CSA).

Mytesi
Generic Name:
crofelemer
Imprint:
125SLXP
Strength:
crofelemer delayed-release 125 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antidiarrheals
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Napo Pharmaceuticals, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide